These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. (18)F-FDG PET/CT and MRI findings in a patient with anti-GABA(B) receptor encephalitis. Su M; Xu D; Tian R Clin Nucl Med; 2015 Jun; 40(6):515-7. PubMed ID: 25608169 [TBL] [Abstract][Full Text] [Related]
11. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Malter MP; Helmstaedter C; Urbach H; Vincent A; Bien CG Ann Neurol; 2010 Apr; 67(4):470-8. PubMed ID: 20437582 [TBL] [Abstract][Full Text] [Related]
12. Opsoclonus myoclonus syndrome in a patient with Japanese encephalitis: a case report. Sountharalingam S; Herath HMMTB; Wijegunasinghe D; Senanayke S J Med Case Rep; 2017 Oct; 11(1):294. PubMed ID: 29058581 [TBL] [Abstract][Full Text] [Related]
13. N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis. Smith JH; Dhamija R; Moseley BD; Sandroni P; Lucchinetti CF; Lennon VA; Kantarci OH Arch Neurol; 2011 Aug; 68(8):1069-72. PubMed ID: 21825245 [TBL] [Abstract][Full Text] [Related]
14. Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome. Fühlhuber V; Bick S; Kirsten A; Hahn A; Gerriets T; Tschernatsch M; Kaps M; Preissner KT; Blaes F; Altenkämper S J Neuroimmunol; 2009 May; 210(1-2):87-91. PubMed ID: 19339060 [TBL] [Abstract][Full Text] [Related]
16. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS). Krasenbrink I; Fühlhuber V; Juhasz-Boess I; Stolz E; Hahn A; Kaps M; Hero B; Blaes F Neuropediatrics; 2007 Jun; 38(3):114-6. PubMed ID: 17985258 [TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis. Kim TJ; Lee ST; Shin JW; Moon J; Lim JA; Byun JI; Shin YW; Lee KJ; Jung KH; Kim YS; Park KI; Chu K; Lee SK J Neuroimmunol; 2014 May; 270(1-2):45-50. PubMed ID: 24662003 [TBL] [Abstract][Full Text] [Related]
18. Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies. Armangué T; Sabater L; Torres-Vega E; Martínez-Hernández E; Ariño H; Petit-Pedrol M; Planagumà J; Bataller L; Dalmau J; Graus F JAMA Neurol; 2016 Apr; 73(4):417-24. PubMed ID: 26856612 [TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine tumour metastatic brain disease during immunosuppressive treatment for paraneoplastic GABA André A; Félix A; Shamasna M; Nzwalo H; Basílio C J Neuroimmunol; 2017 Sep; 310():66-68. PubMed ID: 28778447 [TBL] [Abstract][Full Text] [Related]
20. Commentary for "Opsoclonus myoclonus syndrome associated with GQ1b antibodies". Espay AJ Mov Disord; 2012 Nov; 27(13):1616-7. PubMed ID: 23192923 [No Abstract] [Full Text] [Related] [Next] [New Search]